Michael Hoffman - Onconova Therapeutics Insider

ONTX -- USA Stock  

USD 0.54  0.015  2.88%

Chairman of the Board

Mr. Michael B. Hoffman serves as Chairman of the Board of Onconova Therapeutics, Inc., since 2006. He is a member of the board of directors since December 2002. Since 2003, Mr. Hoffman was a managing director of Riverstone Holdings LLC, or Riverstone, where he is principally responsible for investments in power and renewable energy. Before joining Riverstone, Mr. Hoffman was senior managing director and head of the mergers and acquisitions advisory business of The Blackstone Group L.P., or Blackstone, where he also served on the firm principal group investment committee as well as its executive committee. Prior to joining Blackstone, Mr. Hoffman was managing director and cohead of the mergers and acquisitions department at Smith Barney, Harris Upham Co
Age: 65  Chairman Since 2006  MBA    
267-759-3680  http://www.onconova.com
Hoffman received his Bachelor and Master Degrees from Northwestern University and his M.B.A. from the Harvard Business School.

Michael Hoffman Latest Insider Activity

Michael Hoffman 3 days ago via Macroaxis 
Toro exotic insider transaction detected
Michael Hoffman over a week ago via Macroaxis 
Sale by Michael Hoffman of 225 shares of Toro
Michael Hoffman over two weeks ago via Macroaxis 
Toro exotic insider transaction detected
Michael Hoffman over two weeks ago via Macroaxis 
Toro exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of (114.03) % which means that it has lost $114.03 on every $100 spent on asset. This is way below average.

Similar Executives

Entity Summary

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule product candidates to treat cancer. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania. Onconova Therapeutics operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 25 people.Onconova Therapeutics (ONTX) is traded on Nasdaq Capital Markets in USA. It is located in PENNSYLVANIA, U.S.A and employs 25 people. Onconova Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.

Onconova Therapeutics Leadership Team

Henry Bienen, Director
Ramesh Kumar, CEO, Ph.D
Anne VanLent, Director
Ajay Bansal, CFO, MBA
Premkumar Reddy, Director, Ph.D
Jerome Groopman, Director
James Marino, Director
Manoj Maniar, SVP, MBA
Thomas McKearn, President
Michael Hoffman, Chairman, MBA
Jack Stover, Director
Steven Fruchtman, President
Mark Guerin, VP
Viren Mehta, Director, MBA

Stock Performance Indicators

Did you try this?

Run Alpha Finder Now

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Alpha Finder

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally take a look at Your Equity Center. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.